| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000123 | histone acetyltransferase complex | 4 | 7 |
| GO:0031248 | protein acetyltransferase complex | 3 | 7 |
| GO:0032991 | protein-containing complex | 1 | 7 |
| GO:0140535 | intracellular protein-containing complex | 2 | 7 |
| GO:1902493 | acetyltransferase complex | 4 | 7 |
| GO:1902494 | catalytic complex | 2 | 7 |
| GO:1990234 | transferase complex | 3 | 7 |
| GO:0005654 | nucleoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HF24
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006325 | chromatin organization | 4 | 7 |
| GO:0006473 | protein acetylation | 6 | 7 |
| GO:0006475 | internal protein amino acid acetylation | 7 | 7 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
| GO:0008152 | metabolic process | 1 | 7 |
| GO:0009987 | cellular process | 1 | 7 |
| GO:0016043 | cellular component organization | 3 | 7 |
| GO:0016570 | histone modification | 5 | 7 |
| GO:0016573 | histone acetylation | 6 | 7 |
| GO:0018193 | peptidyl-amino acid modification | 5 | 7 |
| GO:0018205 | peptidyl-lysine modification | 6 | 7 |
| GO:0018393 | internal peptidyl-lysine acetylation | 8 | 7 |
| GO:0018394 | peptidyl-lysine acetylation | 7 | 7 |
| GO:0019538 | protein metabolic process | 3 | 7 |
| GO:0036211 | protein modification process | 4 | 7 |
| GO:0043170 | macromolecule metabolic process | 3 | 7 |
| GO:0043412 | macromolecule modification | 4 | 7 |
| GO:0043543 | protein acylation | 5 | 7 |
| GO:0044238 | primary metabolic process | 2 | 7 |
| GO:0071704 | organic substance metabolic process | 2 | 7 |
| GO:0071840 | cellular component organization or biogenesis | 2 | 7 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 1 |
| GO:0016740 | transferase activity | 2 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.479 |
| CLV_NRD_NRD_1 | 253 | 255 | PF00675 | 0.530 |
| CLV_NRD_NRD_1 | 294 | 296 | PF00675 | 0.629 |
| CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.637 |
| CLV_NRD_NRD_1 | 323 | 325 | PF00675 | 0.656 |
| CLV_NRD_NRD_1 | 40 | 42 | PF00675 | 0.348 |
| CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.538 |
| CLV_PCSK_FUR_1 | 319 | 323 | PF00082 | 0.632 |
| CLV_PCSK_KEX2_1 | 253 | 255 | PF00082 | 0.624 |
| CLV_PCSK_KEX2_1 | 294 | 296 | PF00082 | 0.625 |
| CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.637 |
| CLV_PCSK_KEX2_1 | 319 | 321 | PF00082 | 0.659 |
| CLV_PCSK_KEX2_1 | 322 | 324 | PF00082 | 0.654 |
| CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.348 |
| CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.538 |
| CLV_PCSK_PC7_1 | 319 | 325 | PF00082 | 0.713 |
| DEG_SCF_FBW7_1 | 92 | 98 | PF00400 | 0.592 |
| DEG_SPOP_SBC_1 | 117 | 121 | PF00917 | 0.503 |
| DEG_SPOP_SBC_1 | 240 | 244 | PF00917 | 0.666 |
| DEG_SPOP_SBC_1 | 97 | 101 | PF00917 | 0.592 |
| DOC_CKS1_1 | 92 | 97 | PF01111 | 0.593 |
| DOC_MAPK_MEF2A_6 | 46 | 55 | PF00069 | 0.566 |
| DOC_PP1_RVXF_1 | 203 | 209 | PF00149 | 0.531 |
| DOC_PP4_FxxP_1 | 208 | 211 | PF00568 | 0.514 |
| DOC_PP4_FxxP_1 | 25 | 28 | PF00568 | 0.576 |
| DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.628 |
| DOC_USP7_MATH_1 | 183 | 187 | PF00917 | 0.457 |
| DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.569 |
| DOC_WW_Pin1_4 | 122 | 127 | PF00397 | 0.652 |
| DOC_WW_Pin1_4 | 167 | 172 | PF00397 | 0.722 |
| DOC_WW_Pin1_4 | 207 | 212 | PF00397 | 0.516 |
| DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.481 |
| DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.592 |
| LIG_14-3-3_CanoR_1 | 141 | 149 | PF00244 | 0.697 |
| LIG_14-3-3_CanoR_1 | 214 | 221 | PF00244 | 0.705 |
| LIG_14-3-3_CanoR_1 | 238 | 245 | PF00244 | 0.574 |
| LIG_14-3-3_CterR_2 | 322 | 327 | PF00244 | 0.631 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.659 |
| LIG_BRCT_BRCA1_1 | 143 | 147 | PF00533 | 0.651 |
| LIG_BRCT_BRCA1_1 | 280 | 284 | PF00533 | 0.546 |
| LIG_BRCT_BRCA1_2 | 280 | 286 | PF00533 | 0.545 |
| LIG_FHA_1 | 21 | 27 | PF00498 | 0.441 |
| LIG_FHA_1 | 58 | 64 | PF00498 | 0.489 |
| LIG_LIR_Apic_2 | 23 | 28 | PF02991 | 0.417 |
| LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.479 |
| LIG_RPA_C_Fungi | 36 | 48 | PF08784 | 0.235 |
| LIG_SH2_CRK | 140 | 144 | PF00017 | 0.568 |
| LIG_SH3_3 | 120 | 126 | PF00018 | 0.592 |
| LIG_SH3_3 | 177 | 183 | PF00018 | 0.646 |
| LIG_SH3_3 | 89 | 95 | PF00018 | 0.588 |
| LIG_SUMO_SIM_par_1 | 88 | 94 | PF11976 | 0.594 |
| MOD_CDK_SPxxK_3 | 207 | 214 | PF00069 | 0.510 |
| MOD_CK1_1 | 156 | 162 | PF00069 | 0.646 |
| MOD_CK1_1 | 170 | 176 | PF00069 | 0.595 |
| MOD_CK1_1 | 194 | 200 | PF00069 | 0.592 |
| MOD_CK1_1 | 217 | 223 | PF00069 | 0.518 |
| MOD_CK1_1 | 241 | 247 | PF00069 | 0.669 |
| MOD_CK1_1 | 99 | 105 | PF00069 | 0.556 |
| MOD_CK2_1 | 207 | 213 | PF00069 | 0.514 |
| MOD_CK2_1 | 222 | 228 | PF00069 | 0.530 |
| MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.599 |
| MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.704 |
| MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.596 |
| MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.545 |
| MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.500 |
| MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.504 |
| MOD_GlcNHglycan | 265 | 268 | PF01048 | 0.735 |
| MOD_GlcNHglycan | 313 | 316 | PF01048 | 0.616 |
| MOD_GSK3_1 | 118 | 125 | PF00069 | 0.710 |
| MOD_GSK3_1 | 165 | 172 | PF00069 | 0.682 |
| MOD_GSK3_1 | 191 | 198 | PF00069 | 0.541 |
| MOD_GSK3_1 | 20 | 27 | PF00069 | 0.444 |
| MOD_GSK3_1 | 230 | 237 | PF00069 | 0.558 |
| MOD_GSK3_1 | 239 | 246 | PF00069 | 0.596 |
| MOD_GSK3_1 | 307 | 314 | PF00069 | 0.578 |
| MOD_GSK3_1 | 65 | 72 | PF00069 | 0.322 |
| MOD_GSK3_1 | 91 | 98 | PF00069 | 0.600 |
| MOD_N-GLC_1 | 156 | 161 | PF02516 | 0.654 |
| MOD_NEK2_1 | 127 | 132 | PF00069 | 0.527 |
| MOD_NEK2_1 | 164 | 169 | PF00069 | 0.524 |
| MOD_NEK2_1 | 234 | 239 | PF00069 | 0.593 |
| MOD_NEK2_1 | 96 | 101 | PF00069 | 0.556 |
| MOD_PK_1 | 40 | 46 | PF00069 | 0.403 |
| MOD_PKA_1 | 40 | 46 | PF00069 | 0.413 |
| MOD_PKA_2 | 40 | 46 | PF00069 | 0.413 |
| MOD_Plk_1 | 20 | 26 | PF00069 | 0.454 |
| MOD_Plk_1 | 307 | 313 | PF00069 | 0.533 |
| MOD_Plk_4 | 20 | 26 | PF00069 | 0.454 |
| MOD_Plk_4 | 69 | 75 | PF00069 | 0.332 |
| MOD_ProDKin_1 | 122 | 128 | PF00069 | 0.655 |
| MOD_ProDKin_1 | 167 | 173 | PF00069 | 0.723 |
| MOD_ProDKin_1 | 207 | 213 | PF00069 | 0.514 |
| MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.474 |
| MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.591 |
| TRG_DiLeu_BaEn_2 | 20 | 26 | PF01217 | 0.622 |
| TRG_DiLeu_BaLyEn_6 | 123 | 128 | PF01217 | 0.518 |
| TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.574 |
| TRG_ER_diArg_1 | 293 | 295 | PF00400 | 0.562 |
| TRG_ER_diArg_1 | 319 | 322 | PF00400 | 0.658 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P7C1 | Leptomonas seymouri | 52% | 100% |
| A0A3S7WZY7 | Leishmania donovani | 75% | 99% |
| E9ACT4 | Leishmania major | 76% | 100% |
| E9AHB5 | Leishmania infantum | 75% | 99% |
| E9AYF8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 99% |